BMRN vs HAS · P/E 40, rev $2.85B vs P/E 25, rev $4.75B
Biomarin Pharmaceutical Inc (BMRN) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the BMRN and HAS stock pages for the full models.
Not investment advice.